NFKB1 and acute lymphoblastic leukemia: We investigated the clinical relevance of the NF-κB pathway in the context of MTX resistance by analyzing the publicly available gene expression data of a cohort of 161 therapy-naïve, newly diagnosed pediatric cases of ALL which were published by Sorich et al. [25].